Cardiology Today Current Issue
The following articles appeared in the print edition of Cardiology Today.
Table of Contents
- For CVD prevention, evidence on vitamins inconclusive at best Erik Swain
-
- New AF ablation techniques on horizon to address current challenges Takuma Yamada, MD, PhD; Tom McElderry, MD
- FDA approves ablation catheter for treatment of certain arrhythmias
- FDA approves Eliquis to prevent DVT after hip, knee replacement surgery
- FDA panel votes against recommending approval for serelaxin
- FDA to review heart failure risk associated with saxagliptin
- Ablation yielded lower recurrence rates than antiarrhythmic drugs in paroxysmal AF
- ACCORD MIND: Intensive BP therapy failed to lower cognitive decline in diabetes
- Drug adjustment could be preferable to renal denervation in resistant hypertension
-
- Anticoagulants prescribed more frequently in AF patients, underused in elderly
- Apixaban outperformed warfarin in reducing stroke, systemic embolism risk
- Azithromycin, levofloxacin may increase cardiac risks
- Blood conservation strategy helped reduce transfusions during AVR
- CT imaging did not interfere with cardiac rhythm management devices
- Death of a partner linked to high risk for MI, stroke
- Gestational diabetes may be marker for early atherosclerosis
- Higher parathyroid hormone levels may increase hypertension risk
-
- Initiative helped improve strategies to prevent hospital readmissions
- Mediterranean diet may reduce risk for PAD
- Novel therapy lowered LDL in patients with diabetes, hypercholesterolemia
- Obesity may increase costs, hospital stay in patients with chest pain, dyspnea
- Physical examination continues to provide useful prognostic information in congestive HF
- Policy statement: Noninvasive CV imaging requires patient-focused approach
- Promising results observed for bioresorbable vascular scaffold in STEMI
- RESOLUTE All Comers: ZES, EES yield similar 4-year outcomes
-
- SAFEHEART: Lp(a) predicted CVD in patients with familial hypercholesterolemia
- Serious fall injuries increased in older adults on antihypertensive agents
- TAVR benefits less pronounced in psychological, general health measures
- Transcatheter, surgical approaches comparable in children with certain congenital defects
- Transfusion in PCI associated with adverse events
- Valvular heart disease guideline lowers intervention threshold, provides new disease classification
- Vegetarian diets associated with lower BP
- CMS expands Medicare coverage to include cardiac rehabilitation for chronic HF
-
- Robert Roberts, MD: A trailblazer in molecular cardiology
- Acetaminophen may help prevent kidney injury after pediatric bypass
- Ambulance magnesium failed to improve stroke outcomes
- Delaying heart surgery in newborns may raise risk for brain injury
- Early heart surgery in newborns may reduce neurodevelopmental impairment
- High-sensitivity cardiac troponin T predicted patients with chest pain at minimal risk
- Moderate physical activity may lessen stroke risk in women
- SPS3: Lower BP targets, DAPT did not affect cognition in lacunar stroke
-
- STABILITY: Darapladib misses primary endpoint in stable CHD population
- Stroke risk increased within 24 hours of cocaine use
- Survival rates beyond 15 years achievable for pediatric heart transplant patients
- SYMPLICITY HTN-3 presented: Renal denervation misses primary efficacy endpoint
- TAVR superior to surgery in 1-year survival for high-risk patients
- Transcranial Doppler superior for detection of PFO
- Cangrelor: Not the CHAMPION we hoped for Sara Varnado, PharmD, BCPS, BCCP; Danielle M. Blais, PharmD, BCPS; Hasan Kazmi, PharmD; Sarah A. Spinler, PharmD, FCCP, FAHA, FASHP, AACC, BCPS (AQ Cardiology)
- ESPRIT 1
-
- FAST-MAG
- PREDIMED
- RADAR
- SAFEHEART
- SPS3
- STABILITY
- STAMPEDE